Crossmark

Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis

Published Online: 2021-11-04

Published Print: 2021-12

Authors

Hadi, Fatemeh

Kashefinejad, Shayan

Kamalzadeh, Leila

Hoobehfekr, Saba

Shalbafan, Mohammadreza
License Information

Text and Data Mining valid from 2021-11-04

Version of Record valid from 2021-11-04
More Information

Article History

Received: 5 April 2021

Accepted: 20 October 2021

First Online: 4 November 2021

Declarations

:

: Because of the type of article (Review), there was no need for obtaining ethical approval.

: Not applicable.

: The authors have no conflicts of interest to report.

Document is current